EP2566517
Mótefni sem binda CSF1R
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
4.5.2011EP published:
24.10.2018EP application number:
11778283.9
EP translation filed:
5.12.2018Grant published:
15.1.2019EPO information:
European Patent Register
Max expiry date:
3.5.2031Expiry date:
3.5.2024
Title:
ANTIBODIES THAT BIND CSF1R
Timeline
Today
4.5.2011EP application
24.10.2018EP Publication
5.12.2018Translation submitted
15.1.2019Registration published
3.5.2024Expires
Owner
Name:
Five Prime Therapeutics, Inc.Address:
111 Oyster Point Boulevard, 94080, South San Francisco, CA, US
Inventor
Name:
WONG, JustinAddress:
South San Francisco, CA, US
Name:
VASQUEZ, MaximilianoAddress:
South San Francisco, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
331177 PDate:
4.5.2010Country:
US
Classification
Categories:
A61K 39/395, C07K 16/00, C07H 21/04, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 5.4.2019
Expires: 3.5.2020
Payer: Árnason Faktor
Number: 10
Paid: 27.4.2020
Expires: 3.5.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.4.2021
Expires: 3.5.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.4.2022
Expires: 3.5.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.4.2023
Expires: 3.5.2024
Payer: Árnason Faktor ehf.